Navigation Links
FASEB announces 2014 Science Research Conference: Lipid and Lipid Regulated Kinases in Cancer

Bethesda, MD This 2014 FASEB Science Research Conference focuses on recent advances in our understanding of lipid-regulated signal transduction cascades, lipid mediators, and lipid targets that are known to play major roles in the initiation and progression of human cancers.

This FASEB Conference brings together physician-scientists, basic scientists and scientists from industry for presentations, discussion, and collaboration to broaden our understanding of how these pathways drive cancer, and to explore these and the associated signaling network as targets for cancer therapy. There are numerous challenges in this relatively young, yet rapidly evolving field. Perhaps most critical is understanding the molecular mechanisms by which lipid effectors modulate mitogenesis, cell cycle regulation, cell death and differentiation in transformed cells, and elucidating how intracellular generation of bioactive lipids is altered in transformed cells and contributes to cancer progression.

This meeting strives to provide researchers with an update on current basic, mechanistic discoveries, and to place these discoveries in the proper translational and clinical context. Meeting topics include: The phosphoinostide pathway and its effectors including the protein kinase C (PKC) isozymes, Rho family GTPases, and Ras; modification of membrane phosphoinostides by PI3K, activation of the Akt isozymes and their downstream targets such as mTOR; new phospholipases and the characterization of novel effectors of bioactive products such as COX2 and the isoprostanes; and lipid post-translational modifications of the Ras oncogene and other GTPases that contribute to their transforming activities.


Contact: Robin Crawford
Federation of American Societies for Experimental Biology

Page: 1

Related biology news :

1. FASEB announces 2014 Science Research Conference: Folic Acid, Vitamin B12 and One Carbon Metabolism
2. FASEB announces 2014 SRC: Phospholipid Cell Signaling & Metabolism in Inflammation & Cancer
3. FASEB announces 2014 Science Research Conference: Molecular Biophysics of Membranes
4. FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
5. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
6. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
7. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
8. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
9. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
10. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
11. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
Post Your Comments:
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
Breaking Biology Technology: